InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Haurwitz Rachel E., Présidente et Directrice Générale. Insider active across 2 companies, notably Caribou Biosciences, Inc.. Cumulatively, 5 filings have been published. The latest transaction was filed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations5 total
05,994 shares0
Class A Common Stock
SEC:0001209191-22-038103:0·
€26,18410,000 shares@ €2.61840.012% mcap24.6% of flow
Common Stock
SEC:0001209191-22-028169:0·
€28,01510,000 shares@ €2.80150.013% mcap26.3% of flow
Common Stock
SEC:0001209191-22-028170:0·
€26,18410,000 shares@ €2.61840.012% mcap100.0% of flow
Common Stock
SEC:0001209191-22-005222·
€26,18410,000 shares@ €2.61840.012% mcap24.6% of flow
Common Stock
SEC:0001209191-22-005222:0·
5 of 5 declarations
About Haurwitz Rachel E.
Rachel E. Haurwitz is the President and Chief Executive Officer of Caribou Biosciences, Inc. and Seer, Inc. In these roles, she oversees the operations of both companies and is responsible for implementing their business strategies. Haurwitz plays a key role in directing and managing activities, ensuring that Caribou Biosciences and Seer meet their objectives. Her expertise in the biopharmaceutical sector contributes to the success of both organizations.
